HPV Vaccination For Older Women, Australia

Main Category: Cervical Cancer / HPV Vaccine
Also Included In: Women's Health / Gynecology
Article Date: 17 Feb 2008 - 13:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:2 and a half stars

2.5 (2 votes)

Healthcare Prof:4 and a half stars

4.4 (5 votes)

Article Opinions: 1 posts

The question of whether it is appropriate to vaccinate older women against Human papillomavirus (HPV) is presented for debate in the latest issue of the Medical Journal of Australia.

Dr Rachel Skinner - Senior Lecturer at the School of Paediatrics and Child Health at the University of Western Australia - and her co-authors provide a review of the available information and evidence to help doctors advise women over 26 years of age on the risks and benefits of HPV vaccination.

HPVs are the major cause of cervical cancer. Cervical cancer mortality rates in Australia have been reduced through effective screening programs but there are still 800 new cases of cervical cancer and 300 deaths each year.

Two HPV vaccines are currently available for girls aged 12 and older, through a school immunisation program, and to all women up to the age of 26 years through their GP.

"Recently, a bivalent HPV vaccine has been licensed for use in women aged up to 45 years. Older women have robust immune responses to this vaccine and so should derive benefit from vaccination if they are exposed to HPV type 16 or 18 in the future," Dr Skinner says.

"Despite the vaccine's effectiveness in individual women, it is unlikely the Federal Government will fund a vaccination program for women over the age of 26 as it is not likely to be cost-effective.

"However, if a woman up to the age of 45 years desires protection against cervical disease over and above regular Pap screening, and is prepared to pay for this vaccine, there is considerable potential for individual benefit.

"HPV infection is most common in women under 25 years, drops significantly from 30 years of age, and then appears to increase again in those over 45 years.

"Clinical trials evidence shows that vaccination will have no effect on current or prevalent disease, but should provide a high level of protection from future infection."

The Medical Journal of Australia is a publication of the Australian Medical Association.

Australian Medical Association

Article adapted by Medical News Today from original press release.
Visit our cervical cancer / hpv vaccine section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Australian Medical Association EMB. "HPV Vaccination For Older Women, Australia." Medical News Today. MediLexicon, Intl., 17 Feb. 2008. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/97258.php>

APA
Australian Medical Association EMB. (2008, February 17). "HPV Vaccination For Older Women, Australia." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/97258.php.

Please note: If no author information is provided, the source is cited instead.


Cervical Cancer / HPV Vaccine

Most Popular Articles



Follow Our Cervical Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cervical Cancer / HPV Vaccine Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »